The Securities and Exchange Commission and Federal Trade Commission are investigating Abbott Laboratories’ baby-formula business, the company said.
The SEC’s enforcement division sent a subpoena to Abbott ABT,
In addition, Abbott said it received a civil investigative demand from the FTC in January seeking information in connection with the agency’s investigation of companies that bid for infant-formula supply contracts with a federal program.
Abbott, of Abbott Park, Ill., is cooperating with the government investigations, a spokesman said.
Top stories from WSJ.com